News Center

Home page

Peak Report

News reports

Ye Xuying: Accumulate Experience and Innovate

Release time:

2023-03-21

In Jianfeng Health Technology Company, when it comes to people who know the production equipment best, most people think of Ye Xuying first.

Ye Xuying entered Peak Health in 2015 and has been the manager of the production department. He is mainly responsible for the production management of three workshops: health care products, Chinese herbal pieces and plant extraction. He said that he has been engaged in drug and extract related work since graduation, and has been in the production line for more than 20 years. No matter what type of production line, most of the equipment principles are similar, and he is very interested in mechanical equipment. As long as you look at the circuit diagram and know the principle of the equipment, you will basically understand the operating performance of the equipment. Therefore, in the production process, if there is a problem with the equipment, the operator will first find him to solve it. However, he has always advocated that workshop employees can carry out simple tasks such as equipment maintenance by themselves, because they can improve efficiency. Especially in the clean area, it takes a long time for the mechanic to clean and disinfect. If the employee can solve the small problem by himself, the downtime of the equipment can be greatly saved. When

Ye Xu Ying first entered the company, he found that the employees in the workshop were not familiar with the performance of the equipment. There were still some differences between the laboratory process and the production on the production line. Moreover, each employee's understanding and acceptance ability was different. Someone needed to convert the experimental process into the workshop production process and formulate the operation procedures to ensure the smooth production, reduce errors and ensure the product quality. So Ye Xuying, who had just entered the company, became the "bridge" and first improved the product technology in the workshop. In recent years, he has also trained five master operators who can master job operation skills.

The understanding of the equipment process also laid a solid foundation for Ye Xuying's technological innovation and technological transformation. peak health of the main products of rhodiola rosea broken ganoderma lucidum spore powder soft capsule (jingzhi cikang) main raw materials by rhodiola rosea, ganoderma lucidum spore powder, ginseng and other 6 kinds of chinese herbal medicine composition. In the process of pressing the soft capsule, the contents are bonded together after repeated friction and heat generation in the injection pump, resulting in the particle size of the material becoming larger to the level that does not meet the conditions to be met for pressing the soft capsule. When the rubber is pressed, it is easy to leak oil from gaps, thus the soft capsule cannot be pressed continuously, and even the whole batch of soft capsules is scrapped. This problem once restricted the production of Jingzhi Cikang. However, the contents of most soft capsules on the market are relatively single. As long as the fineness of the contents is ensured, the qualified rate of soft capsules will be very high. Because there is no ready-made reference experience, Ye Xuying began his exploration. He optimized the pressing parameters and content preparation process according to the properties of solid materials. He used the existing wall-breaking equipment in the workshop and adopted the wall-breaking crushing treatment method to successfully eliminate the risk of oil leakage of soft capsules, greatly improving the yield of finished products, and theoretically making the products easier to be absorbed by human body.

When it comes to these innovations and renovations, Ye Xuying is like a treasure. Before, a company that made dried blueberries found Spike Health to help decolorize the sugar water soaked in blueberries. During the chat, they said that they wanted to press tablets with blueberry extract to make tableted candy. However, due to the strict requirements on the content of proanthocyanidins, they could not add too many auxiliary materials, and several companies could not solve the technical problem of tableting. In the process of tablet compression, auxiliary materials need to be added for bonding. General adhesives are solid. The content of proanthocyanidins will be reduced if more is added, but the compression is not good if less is added. After learning about this situation, Ye Xuying's brain turned again, since the solid is not good, what about the liquid? The nature of blueberry extract is quite special, and it can dissolve with many kinds of organic solvents, so he started a round of attempts by using this characteristic. At present, it has successfully provided 3 pilot samples to the other party, and has reached the quality requirements of tablets in terms of appearance color, product content, hardness, etc. The preparation method also applied for an invention patent.

Ye Xuying said that his innovations and inventions are all derived from years of work experience and familiarity with equipment and technology. In recent years, he has applied for 6 patents, participated in a number of government projects, developed a number of new products, and was also rated as the 2022 "Outstanding Enterprise Science and Technology Talent" in Wucheng District ". In his heart, there is a good wish, that is, Peak Health can achieve breakthroughs with the joint efforts of everyone, use modern technology to accelerate the progress of digitization, build a digital chemical factory, and strengthen and grow the health industry. And he is working with his colleagues to contribute to this goal. (Ni Yingzhen Chen Shengmu)

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页